Cargando…
Iranian Pulmonary Arterial Hypertension Registry
BACKGROUND: Idiopathic pulmonary arterial hypertension (IPAH) is a fatal disorder with a prevalence of 8.6 per million. We introduce a registry website for IPAH and PAH patients ( www.IPAH.ir) for access and efficient delivery of government-aided and subsidized antihypertensive medications. MATERIAL...
Autores principales: | Masjedi, Mohammad Reza, Fahimi, Fanak, Sharif-Kashani, Babak, Malek Mohammad, Majid, Saliminejad, Leila, Monjazebi, Fateme |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629425/ https://www.ncbi.nlm.nih.gov/pubmed/26528365 |
Ejemplares similares
-
The Effect of Amlodipine and Sildenafil on the NT-ProBNP Level of Patients with COPD-Induced Pulmonary Hypertension
por: Sharif-kashani, Babak, et al.
Publicado: (2014) -
The Relationship between Electrocardiographic Changes and Prognostic Factors in Severely Symptomatic Pulmonary Hypertension
por: Seyyedi, Seyed Reza, et al.
Publicado: (2019) -
Effect of pulmonary hypertension on outcome of pulmonary tuberculosis
por: Marjani, Majid, et al.
Publicado: (2014) -
The Rate of Physicochemical Incompatibilities, Administration Errors. Factors Correlating with Nurses' Errors
por: Fahimi, Fanak, et al.
Publicado: (2015) -
A Pilot Study of Polymorphism of Adrenergic Beta-2 Receptor and Mild Asthma: A Clinical and Pharmacogenetic Study
por: Adimi Naghan, Parisa, et al.
Publicado: (2013)